United Kingdom · Series C startup

Who invested in Tropic Biosciences

4 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Agtech

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$175Mraised across 4 rounds since 2018, from 4 sources

$10MSeries A$253KRound$60MSeries B$105MSeries C
Latest round
Series C, $105MMar 2026
Step-upi
1.8×
Investors
10
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20182020202220242026
$10MSeries A$253KRound$60MSeries B$105MSeries C
First round
Series A, $10M
Jun 2018
Biggest round
$105M
Series C · Mar 2026
Usual gap between rounds
20 months
the median of 3

The rounds

  1. Mar 2026
  2. Aug 2025
    Series B$60M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  3. Dec 2023
    Round$253K

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  4. Jun 2018
    Series A$10M5 new

    Reported by FinSMEs

Funding filed with regulators

Tropic Biosciences filed 4 raises, $512M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Mar 2026$1.8MUK share allotment
  2. Aug 2025$60MUK share allotment
  3. Dec 2023$253KUK share allotment
  4. Feb 2023$450MUK share allotment

Founders and team

From Tropic Biosciences's own website: 20 on the team.

  • Andrew DominyChief Legal Officer
  • Eyal MaoriChief Development Officer
  • Gilad M. GershonChief Technology Officer
  • Jack PeartChief Operating Officer
  • Karen MarklewChief Financial Officer
  • Victoria LawrenceChief People Officer
  • Mark WilliamsVP Product Management
  • Angela ChaparroAssociate Director Finance & Accounting
  • Ben BelldegrunNon-Executive Director
  • Duncan RibbonsDirector of Strategic Delivery
  • Emma GriptonAssociate Director, Technology Sales and Commercial Partnerships
  • Erez VigodmanNon-Executive Director
  • Joy FaucherNon-Executive Director
  • Mihir KekreAssociate Director Business Development
  • Niccolo ManzoniNon-Executive Director
  • Nico SawyerAssociate Director Technology Development and Research
  • Nicole WardAssociate Director of Rice Product Development
  • Philip ZegermanAssociate Director Technology Development and Research

And 2 more on the team.

AdvisersBarbara J. MazurDavid LawrencePaul TengSir David BaulcombeVincent Pétiard

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Polaris PartnersVC firm1round
Temasek HoldingsVC firm1round
IQ CapitalVC firm1round
Forbion Capital PartnersPrivate equity1round
Bits x BitesVC firm1round
Aliment CapitalVC firm1round
Five Seasons Ventures/ Tekfenno record of our own yet1round
Midven-RSFno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Tropic Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Presidio VenturesCorporate VCPer its own site
AgronomicsVC firmPer its own site
Genoa VenturesVC firmPer its own site

Quick answers about Tropic Biosciences

Who invested in Tropic Biosciences?

Tropic Biosciences's investors include Polaris Partners, Temasek Holdings, IQ Capital, Forbion Capital Partners and Future Planet Capital, and 5 more on record.

How much has Tropic Biosciences raised?

Tropic Biosciences has raised $175M across 4 rounds since 2018.

When did Tropic Biosciences last raise?

Tropic Biosciences's most recent round was a Series C of $105M in Mar 2026.

What was Tropic Biosciences's biggest round?

Its most recent round, $105M in Mar 2026, is also its largest on record.

Who backed Tropic Biosciences first?

Tropic Biosciences's first round on record, in Jun 2018, was backed by Emerald Technology Ventures, Bits x Bites and Aliment Capital and 2 others.

What stage is Tropic Biosciences at?

Tropic Biosciences's latest named round is a Series C, in Mar 2026.

Where is Tropic Biosciences based?

Tropic Biosciences is based in the United Kingdom.

Companies like Tropic Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.